Sleep problems and depression are so consistently linked that clinicians consider disrupted sleep both a primary symptom of depression and a risk factor for developing it in the first place (Sleep Foundation). More than 75 percent of people with depression report significant sleep disturbances, yet sleep is often treated as a secondary concern — something that will resolve once mood improves (Mayo Clinic). In many cases, that assumption delays recovery rather than supporting it.
The Relationship Between Depression and Sleep
Depression and sleep disruption do not simply co-occur — they actively reinforce one another through shared neurobiological mechanisms. Understanding this relationship is essential for treating either condition effectively.
Depression affects sleep architecture — the structure and sequence of sleep stages — in measurable ways. People with depression often experience difficulty falling asleep, frequent waking during the night, or early morning waking with an inability to return to sleep. They may also spend more time in lighter sleep stages and less time in the slow-wave and REM (rapid eye movement) sleep stages that are most restorative for mood, memory consolidation, and emotional processing. The Sleep Foundation documents that these disruptions are not incidental — they are part of the neurobiological signature of depression.
What makes this relationship particularly difficult to treat in isolation is that sleep deprivation and fragmented sleep independently worsen the symptoms of depression. Low mood, reduced motivation, cognitive slowing, irritability, and emotional reactivity — all symptoms of depression — are also symptoms of inadequate sleep. When depression impairs sleep and poor sleep deepens depression, the two conditions create a cycle that neither resolves spontaneously.
Why Treating Mood Alone Is Often Not Enough
The conventional approach to depression — starting with antidepressants, adjusting doses, adding medications as needed — addresses the neurochemical dysregulation of mood but does not always directly target sleep architecture. Some antidepressants have sedating properties that may help with sleep onset; others can actually worsen certain sleep parameters, particularly REM sleep. This means that a medication that partially lifts mood may do little to restore the quality of sleep needed for full recovery.
This is one reason patients with depression who achieve a partial treatment response often still report significant fatigue, cognitive fog, and emotional flatness — symptoms that are as attributable to disrupted sleep as to residual depressive neurochemistry. Treating depression comprehensively means addressing both the mood component and the sleep component, not assuming one will follow from the other.
Sleep is also involved in emotional memory consolidation — the process by which the brain processes and contextualizes emotionally significant experiences during REM sleep. When this process is chronically disrupted, emotional regulation suffers, trauma responses can become more entrenched, and the psychological work of recovery becomes harder to sustain. The Sleep Foundation describes the bidirectional relationship between mental health and sleep as foundational to understanding why so many people with depression feel stuck despite partial treatment success. For a closer look at how depression-related cognitive symptoms develop, our post on brain fog and depression explores the underlying mechanisms in detail.
The Glutamate System and Its Role in Both Depression and Sleep
Most first-line antidepressants target serotonin or norepinephrine — neurotransmitter systems that play important roles in mood regulation. But research increasingly points to the glutamate system — the brain’s primary excitatory neurotransmitter network — as central to both depression and sleep regulation. Glutamate signaling influences sleep-wake transitions, slow-wave sleep depth, and the neuroplasticity that occurs during restorative sleep.
The National Institute of Mental Health highlighted research showing that ketamine — which acts primarily on NMDA receptors (N-methyl-D-aspartate receptors, a subtype of glutamate receptor) — produces rapid antidepressant effects through a mechanism that standard medications do not replicate (National Institute of Mental Health, 2024). Some patients who respond to ketamine treatment in Alexandria, VA also report improvements in sleep quality alongside mood, though individual responses vary and sleep improvement is not a guaranteed outcome of ketamine therapy.
The relevance here is that targeting the glutamate system may address components of depression that SSRIs and SNRIs do not reach directly — including the neurobiological underpinnings of disrupted sleep architecture. This does not mean ketamine is a sleep medication, and we do not position it as one. But for patients whose depression and sleep disruption are both inadequately treated, the shared neurobiological mechanisms are worth understanding.
What We Assess and Offer at Nova Health Recovery
At Nova Health Recovery, we treat depression as a whole-system condition. Dr. Christopher Sendi, M.D., is board certified in addiction medicine, obesity medicine, internal medicine, emergency medicine, and pain management, with more than 21 years of clinical experience. Before recommending any treatment, we review the full picture: the history of the depressive episode, what has been tried and at what doses, what symptoms remain and how severe they are, and how sleep fits into the overall presentation.
For patients with depression that has not responded adequately to standard antidepressants — particularly when significant residual symptoms including sleep disruption remain — we offer IV ketamine infusion therapy. The standard loading protocol involves four to six infusions administered twice weekly over two to three weeks, with each visit running approximately 90 to 120 minutes and the active infusion lasting around 40 minutes. Because ketamine produces dissociative effects during infusion, a driver is required for all in-clinic visits. Patients who respond to the initial series and reach a stable baseline may be candidates for at-home ketamine therapy — oral troches or a compounded nasal spray — as a continuation option. These are compounded racemic ketamine formulations, distinct from SPRAVATO® (esketamine), which is an FDA-approved intranasal formula available only in certified clinical settings.
We take sleep seriously as part of the treatment picture, not as an afterthought. If sleep disruption is a significant feature of a patient’s presentation, that informs how we approach evaluation and which options we discuss. We encourage patients to describe their full symptom picture — including sleep — during their initial consultation.
The Cost Question and Getting Started
We hear from patients regularly who have put off seeking care because they are not sure what treatment will cost or whether they will be able to manage the time commitment. Nova Health Recovery does not accept insurance directly, but we provide a SuperBill — an itemized treatment statement — that you can submit to your insurer for potential out-of-network reimbursement. Coverage varies by plan, and we encourage you to check with your insurer before assuming the cost is prohibitive. Our team is available at 703-952-1876 around the clock to walk through the details of the consultation process and answer logistical questions before you commit to anything.
The time commitment of a full in-clinic infusion series is real — two sessions per week over several weeks is a meaningful ask. For patients who complete the series and transition to at-home maintenance, that burden reduces considerably. Telemedicine follow-up is available for ongoing monitoring after the initial treatment phase, which reduces the number of in-person visits required over time. We discuss scheduling openly from the first call. Results vary by individual, and we do not make guarantees about treatment outcomes.
Frequently Asked Questions
Does depression cause insomnia or does insomnia cause depression? Both are true, and the relationship runs in both directions. Depression disrupts sleep architecture — particularly slow-wave and REM sleep — and poor sleep independently worsens depression symptoms including mood, cognition, and emotional regulation. Treating one without addressing the other often produces incomplete recovery. Discuss both with your provider as part of the same clinical picture.
Why do some antidepressants make sleep worse? Some antidepressants — particularly those that affect REM sleep — can actually reduce certain restorative sleep stages even while improving mood. This is one reason patients on antidepressants sometimes feel less emotionally depressed but still fatigued, cognitively slow, or emotionally flat. If your sleep has not improved or has worsened since starting a medication, that is worth raising with your provider.
Can ketamine help with depression-related sleep problems? Ketamine acts on the glutamate system, which plays a role in sleep-wake regulation as well as mood. Some patients report sleep improvements alongside mood improvement following ketamine treatment, though this varies significantly by individual and sleep improvement is not a primary or guaranteed outcome of ketamine therapy. If sleep disruption is a significant part of your presentation, we include that in our clinical assessment.
What if I’ve been treated for depression but still can’t sleep? Residual sleep disruption after partial depression treatment is common and clinically recognized. It may reflect incomplete treatment of the depression itself, treatment that has not addressed relevant neurobiological pathways, or sleep disruption that has become partly independent of mood. An evaluation that takes both into account — rather than treating sleep and mood as separate problems — is a reasonable next step.
How do I know if my sleep problems are related to depression or something else? Sleep disruption has many possible contributors: anxiety, sleep apnea, medication effects, circadian rhythm disruption, chronic pain, and others. A thorough clinical evaluation will help clarify what is driving your specific sleep picture. If depression is part of the presentation, addressing it effectively tends to improve sleep in most patients — though the timeline and degree of improvement vary.
Key Takeaways
- Depression disrupts sleep architecture, including slow-wave and REM sleep stages, and poor sleep independently worsens depression — creating a reinforcing cycle that neither resolves spontaneously.
- Treating depression without addressing sleep often produces incomplete recovery; residual fatigue, cognitive fog, and emotional flatness may be partly attributable to ongoing sleep disruption rather than mood symptoms alone.
- The glutamate system plays a role in both depression and sleep regulation; ketamine’s mechanism of action — targeting NMDA receptors — may address aspects of both, though individual response varies.
- At Nova Health Recovery, sleep is treated as a meaningful component of the clinical picture, not a secondary symptom that will resolve on its own.
- Nova Health Recovery does not accept insurance directly but provides a SuperBill for out-of-network reimbursement claims, and telemedicine follow-up is available to reduce the in-person burden after initial treatment. Results vary by individual.
Depression and sleep are not separate problems waiting to be treated in sequence. At Nova Health Recovery, we evaluate them together as part of the same clinical picture. If your sleep has not improved alongside your mood — or if depression and sleep disruption are both inadequately treated — call 703-952-1876 at any time or schedule a consultation with Dr. Sendi to discuss what your options are.
References
Sleep Foundation — Sleep and Mental Health: https://www.sleepfoundation.org/mental-health
Mayo Clinic — Symptoms of Depression: https://www.mayoclinic.org/diseases-conditions/depression/symptoms-causes/syc-20356007
National Institute of Mental Health — New Hope for Rapid-Acting Depression Treatment (2024): https://www.nimh.nih.gov/news/science-updates/2024/new-hope-for-rapid-acting-depression-treatment
Medical Disclaimer
The information in this blog is provided for educational purposes only and does not constitute medical advice. Depression, sleep disruption, and their relationship vary significantly between individuals, and no treatment — including ketamine therapy — produces the same results for everyone. Individual results vary. Nothing in this content should be used to self-diagnose or self-treat any condition. Please consult a qualified medical provider familiar with your full medical and psychiatric history before making any treatment decisions. If you are experiencing a mental health crisis or thoughts of self-harm, call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.